TITLE:
A Study Comparing 4 Doses Of GW810781 Versus Placebo In HIV-Infected Patients

CONDITION:
HIV Infections

INTERVENTION:
GW810781

SUMMARY:

      This study will evaluate the drop in viral load over 10 days of treatment with S-1360 versus
      placebo in HIV-infected patients who have not previously taken anti-HIV medications.
    

DETAILED DESCRIPTION:
NONE

ELIGIBILITY:
Gender: All
Age: 18 Years to N/A
Criteria:

        Inclusion Criteria:

          -  No prior HIV medications.

          -  HIV infection with viral load >400-50,000 copies/mL.

          -  CD4 cell count >50 cells/mm.

        Exclusion Criteria:

          -  Patients requiring medications that cannot be interrupted for the duration of the
             study.

          -  Abnormal ECG or other chronic health conditions as noted on screening physical exam.

          -  Previous participation in an experimental drug trial(s) within 30 days of the
             screening visit for this study.
      
